Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

5(25%)

Results Posted

40%(2 trials)

Terminated

1(5%)

Phase Distribution

Ph early_phase_1

Ph not_applicable

10%

Ph phase_2

60%

Ph phase_3

Ph phase_1

10%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution18 total trials

Early Phase 1First-in-human

1(5.6%)

Phase 1Safety & dosage

2(11.1%)

Phase 2Efficacy & side effects

12(66.7%)

Phase 3Large-scale testing

1(5.6%)

N/ANon-phased studies

2(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(10)

Completed(5)

Terminated(2)

Other(3)

Detailed Status

Completed5

Not yet recruiting4

Recruiting4

unknown3

Terminated1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 3

Trials by Phase

Early Phase 11 (5.6%)

Phase 12 (11.1%)

Phase 212 (66.7%)

Phase 31 (5.6%)

N/A2 (11.1%)

Trials by Status

terminated15%

active_not_recruiting15%

not_yet_recruiting420%

unknown315%

recruiting420%

completed525%

withdrawn15%

enrolling_by_invitation15%

Recent Activity

5 active trials

Showing 5 of 20

enrolling_by_invitationphase_2

Efficacy of Topical Cannabidiol for Eczema

NCT06994520

recruitingphase_2

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

NCT05269628

not_yet_recruitingphase_2

Clinical Trials (20)

Showing 20 of 20 trials

NCT06994520Phase 2

Efficacy of Topical Cannabidiol for Eczema

Enrolling By Invitation

NCT05269628Phase 2

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Recruiting

NCT07148843Phase 2

Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving

Not Yet Recruiting

NCT07638189Phase 2

CBD Knee Osteoarthritis Study

Not Yet Recruiting

NCT05020028Phase 2

Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis

Recruiting

NCT05836857

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

Active Not Recruiting

NCT05753007Phase 2

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Terminated

NCT07434973Phase 3

Stratification and Treatment in Early Psychosis Study - PROMOTE

Not Yet Recruiting

NCT02556008

Cannabidiol for Pediatric Epilepsy (Compassionate Use)

Unknown

NCT04567784Phase 2

Neuroimaging and CBD for Opioid Use Disorder

Completed

NCT07167446Early Phase 1

Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

Recruiting

NCT04992624Phase 2

Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee

Recruiting

NCT04754399Phase 2

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

Completed

NCT06695195Phase 1

A Randomized Controlled Trial of Oral CBD for the Treatment of Upper Extremity Musculoskeletal Pain

Not Yet Recruiting

NCT06286839Not Applicable

Study of Cannabidiol (CBD) in Healthy Volunteers

Completed

NCT05387148Phase 2

The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol Dependence

Unknown

NCT04881539Not Applicable

CBD, Immune Function, and Neural Health

Completed

NCT03883360Phase 2

Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis

Withdrawn

NCT04193631Phase 1

Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain

Completed

NCT02255292Phase 2

A Study: Pure CBD as Single-agent for Solid Tumor.

Unknown

All 20 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 20